Health News & Press Release Distribution

Health

APAC
Global

World-renowned therapist and wellness expert Marisa Peer endorses natural prebiotic Kfibre & Kfibre Pro Synbiotics for advanced gut health management.

Heal the Gut, Heal the Mind SYDNEY, Feb. 23, 2023 /PRNewswire/ -- As a pioneering therapist, speaker, best-selling author, and the founder of Rapid Transformational Therapy (RTT®), Marisa's guiding ethos is centred on simple steps that produce dramatic and life-saving results. One of those step...

2023-02-23 13:31 1887

Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901

CHENGDU, China, Feb. 23, 2023 /PRNewswire/ -- Keymed Biosciences Inc., ("Keymed") (Stock Code: 02162 HK) and Lepu Biopharma Co., Ltd, (Stock Code: 02157.HK) today jointly announce a global exclusive licence agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for CMG901, a potential first-in-class C...

2023-02-23 13:01 1832

Lepu Biopharma and Keymed Jointly Announces Global Exclusive Licence Agreement with AstraZeneca for CMG901

HONG KONG, Feb. 22, 2023 /PRNewswire/ -- Lepu Biopharma Co., Ltd. (Stock Code: 02157.HK) and Keymed Biosciences Inc., ("Keymed") (Stock Code: 02162 HK) today jointly announces a global exclusive licence agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for CMG901, a potential first-in-class Claudi...

2023-02-23 12:26 2459

Dawn Health partners with leading pharmaceutical company to transform chronic care

COPENHAGEN, Denmark, Feb. 23, 2023 /PRNewswire/ -- Dawn Health, a global leader in digital health, today announced a strategic partnership with Novartis, one of the leading medicines companies in the world, to support the development of a platform that enables the effective remote monitoring and ...

2023-02-23 12:16 1662

Trip.com Group aids community recovery through Turkish earthquake relief initiative

SHANGHAI, Feb. 23, 2023 /PRNewswire/ -- Trip.com Group, a leading global online travel services provider, is offering aid and assistance to help support victims of the devastatingTurkey-Syria earthquakes that have affected communities throughout the country. Trip.com Group has donated 3,400 eme...

2023-02-23 09:00 2090

Trip.com Group aids community recovery through Turkish earthquake relief initiative

EVERSANA CONSULTING Named a Top Ranked Consulting Firm by Vault Across Asia Pacific

SINGAPORE and CHICAGO, Feb. 22, 2023 /PRNewswire/ -- EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, today announced its strategic consulting armEVERSANA® CONSULTING, has been named to Vault's 2023 Top Consulting Ranking in the Asia Pacific (APAC)...

2023-02-22 23:01 2320

150th Anniversary of Dr. Hansen's Discovery of M. leprae Is Opportunity to Examine Past, Present and Future of Leprosy

TOKYO, Feb. 22, 2023 /PRNewswire/ -- The University of Bergen, Norway and Sasakawa Leprosy (Hansen's Disease) Initiative will hold an event inBergen on Feb. 28, 2023, to mark the 150th anniversary of Dr. Gerhard Armauer Hansen's discovery of the leprosy bacillus,M. leprae, in 1873. On the same da...

2023-02-22 22:00 2050

150th Anniversary of Dr. Hansen's Discovery of M. leprae Is Opportunity to Examine Past, Present and Future of Leprosy

Altos Biologics, a Subsidiary of Alteogen, Completed Patient Enrollment in Global Phase 3 Clinical Trial of Eylea® Biosimilar in Neovascular Age-related Macular Degeneration

* Altos Biologics, a subsidiary of Alteogen, is actively engaged in Eylea® Biosimilar (ALT-L9) clinical development and licensing-out discussions. * Early 2024 projected for Phase 3 completion and product launch in Europe expected after obtaining approval in the first half of 2025. DAEJEON, So...

2023-02-22 22:00 2213

Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase

TOKYO, Feb. 22, 2023 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce the development of a new enzyme for double strand oligonucleotide formation with high productivity...

2023-02-22 21:05 2515

GenScript ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate

PISCATAWAY, N.J. and SINGAPORE, Feb. 22, 2023 /PRNewswire/ -- GenScript ProBio, a leading global Contract Development and Manufacturing Organization (CDMO), and RVAC Medicines Pte. Ltd., a biotechnology company focusing on the development and commercialization of messenger RNA (mRNA) therapeu...

2023-02-22 21:00 2461

AnPac Bio Announces Positive Results from its Multi-Year and Multi-Cancer Test Follow-Up Study

NEW YORK, Feb. 22, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (ANPC), a company with operations inthe United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commer...

2023-02-22 20:30 2173

CRT 2023 selects Syntach Cardiac Support System for Best Innovation Competition

LUND, Sweden, Feb. 22, 2023 /PRNewswire/ -- Syntach AB ("Syntach") is pleased to announce that the Company's Syntach Cardiac Support system (Syntach CS) has been selected for an oral presentation in the Best Innovation Competition to be held during the CRT 2023 annual meeting taking place at the ...

2023-02-22 20:22 2221

Fapon Biopharma's Anti-CD47 Antibody FP002 Earns IND Approval from FDA

SHENZHEN, China, Feb. 22, 2023 /PRNewswire/ -- Fapon Biopharma, an innovative biotech company, announced today that its Investigational New Drug (IND) application of FP002, an anti-CD47 monoclonal antibody drug candidate, has been approved by FDA for clinical trials. FP002 is a humanized anti-CD...

2023-02-22 20:17 1857

Karyopharm and Menarini Group Receive Full Marketing Authorization from the UK Medicines & Healthcare Products Regulatory Agency for NEXPOVIO® (selinexor) in Combination with Bortezomib and Dexamethasone for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy

– Based on Results from Phase 3 BOSTON Study, Marketing Authorization Expands Multiple Myeloma Indication – NEWTON, Mass. and FLORENCE, Italy, Feb. 21, 2023 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, an...

2023-02-21 23:04 2862

Commercialization of Gene Therapy is coming soon: Neurophth Completes Patient Enrollment for Phase III clinical trial for the gene therapy treatment of LHON

WUHAN, China and SAN DIEGO, Feb. 21, 2023 /PRNewswire/ -- Neurophth Therapeutics, Inc. ("Neurophth") announced today thatthe last patient has been enrolled in the Phase III clinical trial for the treatment of Leber hereditary optic neuropathy (LHON) inChina. It marks the completion of patient enr...

2023-02-21 21:30 2574

Meihua International Medical Technologies Co., Ltd. Enters Into Cooperation Agreements with Hainan's Qionghai City and Hainan Free Trade Port Boao Hope City to Build Technology Park and Medical Research and Development Center

YANGZHOU, China, Feb. 21, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, today announced the Company, vi...

2023-02-21 20:30 2703

New Study Shows GlycoMark® Test Identifies Prediabetic Individuals with the Highest Risk of Developing Diabetes Before Symptoms Develop

RALEIGH, N.C., Feb. 21, 2023 /PRNewswire/ -- A new study indicates that the GlycoMark blood test identifies high-risk, asymptomatic patients with prediabetes, not detected by standard diabetes tests, hemoglobin A1C and glucose – a critical clinical need, as physicians can identify those patients...

2023-02-21 20:30 1867

NMPA accepted the registration applications for Uro-G and Uro-3500

SHANGHAI, Feb. 21, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that the registration applications for ...

2023-02-21 17:46 1881

Organizational-level, Unified and Vendor-neutral Enterprise Imaging and Informatics Drive Effective Digital Transformation

Scalable enterprise-level solutions leverage all data at an enterprise level and can engage with the entire unified longitudinal patient record SAN ANTONIO, Feb. 21, 2023 /PRNewswire/ -- Medical imaging and healthcare digitalization have seen significant advances and evolution in recent years. T...

2023-02-21 16:12 1877

Synbio Tech Inc. and Cosmax Group signed an exclusive cooperation agreement to jointly expand the South Korean probiotics market

KAOHSIUNG, Taiwan, Feb. 21, 2023 /PRNewswire/ -- Synbio Tech Inc. and Cosmax NBT, a major South Korean biotechnology company officially signed an exclusive cooperation agreement to launchLactobacillus plantarum TWK10® probiotic strain inSouth Korea, and announced that TWK10® has been approved as ...

2023-02-21 16:01 2582

1 ... 265 266 267268269 270 271 ... 848